These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10952766)

  • 21. Bigger isn't always better.
    Nature; 2002 Jul; 418(6896):353. PubMed ID: 12140518
    [No Abstract]   [Full Text] [Related]  

  • 22. Goliath befriends David.
    Clarke T; Pearson H
    Nature; 2001 Nov; 414(6863):482-3. PubMed ID: 11734817
    [No Abstract]   [Full Text] [Related]  

  • 23. Coming back to life Montreal.
    Hoag H
    Nature; 2004 Jul; 430(6996):274-5. PubMed ID: 15241427
    [No Abstract]   [Full Text] [Related]  

  • 24. Standards for pharmaceutical advertising in Canada.
    Chepesiuk R
    CMAJ; 2005 Aug; 173(3):238; author reply 238. PubMed ID: 16076811
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacy practice research careers.
    ; Smith JA; Olson KL; Sowinski KM
    Pharmacotherapy; 2009 Aug; 29(8):1007-11. PubMed ID: 19637956
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationship between pharmaceutical company user fees and drug approvals in Canada and Australia: a hypothesis-generating study.
    Lexchin J
    Ann Pharmacother; 2006 Dec; 40(12):2216-22. PubMed ID: 17132811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Will R&D make Merck hot again?
    Simons J
    Fortune; 2002 Jul; 146(1):89-90, 92, 94. PubMed ID: 12119729
    [No Abstract]   [Full Text] [Related]  

  • 28. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmaceutical industry--to whom is it accountable?
    Jacobs C
    N Engl J Med; 2000 Nov; 343(19):1416-7; discussion 1417. PubMed ID: 11183878
    [No Abstract]   [Full Text] [Related]  

  • 30. The pharmaceutical industry--to whom is it accountable?
    Hayes TA
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183881
    [No Abstract]   [Full Text] [Related]  

  • 31. Deal watch: Ablynx and Merck Serono collaborate on next-generation antibody products.
    Nat Rev Drug Discov; 2008 Nov; 7(11):881. PubMed ID: 18974745
    [No Abstract]   [Full Text] [Related]  

  • 32. The pharmaceutical industry--to whom is it accountable?
    Summers WK; Driscoll J; Orient JM
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183883
    [No Abstract]   [Full Text] [Related]  

  • 33. What does R&D really cost?
    Huff B
    GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiology in the pharmaceutical Industry: A Canadian perspective.
    Rawson NS; De Souza LR
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):758-62. PubMed ID: 16832827
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medical research and the pharmaceutical industry. Uneasy bedfellows or a prenuptial agreement?].
    Schuling J
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1909. PubMed ID: 11605317
    [No Abstract]   [Full Text] [Related]  

  • 36. [Medical research and the pharmaceutical industry. Uneasy bedfellows or a prenuptial agreement?].
    Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1908; author reply 1908-9. PubMed ID: 11605316
    [No Abstract]   [Full Text] [Related]  

  • 37. The pharmaceutical industry: a prescription.
    Woods D
    Can Med Assoc J; 1983 Oct; 129(7):675. PubMed ID: 6616369
    [No Abstract]   [Full Text] [Related]  

  • 38. German chemicals giant to focus on life sciences.
    Schiermeier Q
    Nature; 1998 May; 393(6681):103. PubMed ID: 9603507
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug life-cycle technologies.
    Fleming E; Ma P
    Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
    [No Abstract]   [Full Text] [Related]  

  • 40. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.